Publications

Beutels P. Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination. Vaccine 2004;22:3312-22. [Abstract]

Lawrence GL, Burgess MA, Kass RB. Age-related risk of adverse events following yellow fever vaccination in Australia. Communicable Diseases Intelligence 2004;28:244-8. [Abstract]

Leask J, Williams A, McIntyre P, O'Dea D. Are General Practice Registrars prepared for immunisation? A cross sectional survey. Australian Family Physician 2004;33:665-7. [Abstract]

McIntyre P. Vaccines for other neonatal infections: vaccine strategies for prevention of neonatal pertussis. Expert Review of Vaccines 2004;3:375-8. [Abstract]

De Graeve D, Beutels P. Economic aspects of pneumococcal pneumonia: a review of the literature. Pharmacoeconomics 2004;22:719-40. [Abstract]

Scuffham P, McIntyre P. Pertussis vaccination strategies for neonates - an exploratory cost-effectiveness analysis. Vaccine 2004;22:2953-64. [Abstract]

National Centre for Immunisation Research and Surveillance. Pneumococcal vaccination for children older than two – patient handout. Australian Doctor. 2004 Jul 23;47. [Link]

Brotherton JML, McIntyre PB. Planning for human papillomavirus vaccines in Australia. Report of a research group meeting. Communicable Diseases Intelligence 2004;28:249-54. [Full text]

Hull BP, McIntyre PB. What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? . Communicable Diseases Intelligence 2004;28:238-43. [Abstract]

Brotherton JML. Festschrift for Margaret Burgess. Communicable Diseases Intelligence 2004;28:349-55. [Full text]